Cell membrane disintegration and extracellular vesicle release in a model of different size and charge PAMAM dendrimers effects on cultured endothelial cells
- 7 February 2019
- journal article
- research article
- Published by Taylor & Francis in Nanotoxicology
- Vol. 13 (5) , 664-681
Abstract
Different nanomaterials are under development for various biomedical applications in which nanoparticles contact blood and vasculature. Therefore, investigating the interactions between nanomaterials and vascular endothelial cells (ECs) is of great importance. Here, we show the effects of polyamidoamine (PAMAM) dendrimers of two different sizes, generation 2 (G2; approximately 3 nm diameter) and generation 7 (G7; 9 nm), with neutral (OH-terminated), anionic (COOH-terminated), and cationic (NH2-terminated) surface modifications on cultured human umbilical vein ECs (HUVECs). We found that only cationic dendrimers (5–100 μg/mL G7-NH2 and 100 µg/mL G2-NH2) and not anionic or neutral dendrimers were cytotoxic to HUVECs. In addition, cationic dendrimers at low concentrations (5 μg/mL) markedly increased the HUVEC surface expression of the proinflammatory activation marker ICAM-1 and phosphatidylserine (PS). Both G2-NH2 and G7-NH2 dendrimers caused g1 arrest, but only G7-NH2 dendrimers induced significant HUVEC apoptosis. G7-NH2 interacted strongly with HUVEC plasma membranes and mitochondrial membranes, and phospholipid vesicles containing G7-NH2 formed, which resulted in extensive plasma membrane blebbing and disintegration. Furthermore, flow cytometric analysis showed that G7-NH2-treated HUVECs released large numbers of extracellular vesicles (EVs) positive for CD105 and PS. A notable population of EVs positive for the mitochondrial marker TOM20 but negative for the autophagosome marker LC3 was found. In summary, large cationic PAMAM dendrimers (G7-NH2) showed both proinflammatory and proapoptotic effects in ECs; at high dendrimer concentrations, these effects were accompanied by necrotic cytotoxicity. G7-NH2 caused plasma and mitochondrial membrane disintegration and the release of EVs, including EVs of mitochondrial origin that were not associated with mitophagy.Keywords
Funding Information
- FDA Office of Chief Scientist Collaborative Opportunities for Research Excellence in Science (CORES) internal grant
- internal research funds of the Center for Biologics Evaluation and Research, FDA
This publication has 51 references indexed in Scilit:
- Cationic PAMAM Dendrimers Disrupt Key Platelet FunctionsMolecular Pharmaceutics, 2012
- Mesoporous silica nanoparticles in biomedical applicationsChemical Society Reviews, 2012
- Nanoparticle Size and Surface Charge Determine Effects of PAMAM Dendrimers on Human Platelets in VitroMolecular Pharmaceutics, 2011
- Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cellsToxicology and Applied Pharmacology, 2010
- Poly(amidoamine) Dendrimers on Lipid Bilayers II: Effects of Bilayer Phase and Dendrimer TerminationThe Journal of Physical Chemistry B, 2008
- Nanoscale Protein Pores Modified with PAMAM DendrimersJournal of the American Chemical Society, 2007
- Tissue Factor in Cardiovascular DiseasesCirculation, 2006
- Designing dendrimers for biological applicationsNature Biotechnology, 2005
- The influence of surface modification on the cytotoxicity of PAMAM dendrimersInternational Journal of Pharmaceutics, 2003
- Biocompatibility of Polycations: In Vitro Agglutination and Lysis of Red Blood Cells And In Vivo ToxicityJournal of Drug Targeting, 2002